Does Biopharma Drug Discovery Need to Evolve to Include Objective, Longitudinal, Broad-Spectrum Real-World Data?
XTalks
MARCH 19, 2024
This mirrors what happens in everyday clinical practice, where patients often receive multiple medications before finding an effective treatment. It is well established that drugs for psychiatric conditions suffer some of the lowest approval rates when compared to other major therapeutic areas.
Let's personalize your content